A $100 Million Trial Launched Today to Test Whether GLP-1 Drugs Plus Lifestyle Changes Can Prevent Dementia The Alzheimer's Association today launched a $100 million global clinical trial designed to answer one of the most consequential questions in aging medicine: can combining a GLP-1 receptor agonist drug with a proven lifestyle intervention actually prevent dementia
Tirzepatide is primarily approved for adults with type 2 diabetes to improve glycemic control
The US Food and Drug Administration approved Foundayo for chronic weight management in adults with obesity, or adults with overweight and at least one weight-related comorbidity, on 1 April 2026
The approval and launch of oral Wegovy represent an important development in weight loss treatment, offering patients and employers a new tool in the fight against obesity
Adderall, a stimulant, does not directly increase serotonin levels but can contribute to serotonin syndrome if combined with other serotonergic medications
Led by board-certified OB/GYN Asela Russell, MD, our practice emphasizes whole-person wellness and sustainable progress